FDA to hear plan for buntanetap as Parkinson’s dementia treatment
Annovis Bio has scheduled a January meeting with the U.S. Food and Drug Administration (FDA) to discuss buntanetap…
Articles by Marisa Wexler, MS
Scientists create first visualization of tiny Parkinson’s protein clumps
For the first time, scientists have managed to visualize tiny protein clumps in the brain that are thought to trigger…
Scientists caution on some experimental Parkinson’s therapies
Some experimental therapies for Parkinson’s disease designed to improve the function of mitochondria may inadvertently damage them instead.
Overactive dopamine cells may drive Parkinson’s brain damage
Brain damage in Parkinson’s disease may be driven in part by certain nerve cells working too hard, causing them…
Hemoglobin discovery may offer strategy for Parkinson’s treatment
Hemoglobin — a protein best known for carrying oxygen in the bloodstream — has an under-recognized role in protecting brain…
Parkinson’s advocacy groups call for ‘robustly funded, collaborative NIH’
A trio of prominent Parkinson’s disease advocacy groups are calling on the U.S. federal government to provide strong funding…
Levels of fat molecules altered in brains of Parkinson’s patients: Study
People with Parkinson’s disease have altered levels of certain fat molecules, known as lipids, in their brains, and this…
Parkinson’s gene therapy safe, appears to ease motor symptoms
Treatment with Askbio‘s gene therapy candidate AB-1005 is safe and appears to ease motor symptoms in people with either a…
Eye test can distinguish Parkinson’s from secondary parkinsonism
Imaging of nerves in the eyes may be used to differentiate between Parkinson’s disease and secondary forms of parkinsonism,…
Sensory regions of brain disrupted in Parkinson’s: Mouse study
Nerve cells in the brain that are responsible for processing smells and sight show deficits in Parkinson’s disease, according…